학술논문
BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response - results from the NSCLC cohort
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041